Immediate Impact

25 standout
Sub-graph 1 of 13

Citing Papers

Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
Inflammation in cancer: therapeutic opportunities from new insights
2025 Standout
2 intermediate papers

Works of Tetsuhiro Kasamatsu being referenced

DNA-double strand breaks enhance the expression of major histocompatibility complex class II through the ATM-NF-κΒ-IRF1-CIITA pathway
2021
PDCD1 and PDCD1LG1 polymorphisms affect the susceptibility to multiple myeloma
2019

Author Peers

Author Last Decade Papers Cites
Tetsuhiro Kasamatsu 136 132 67 73 30 301
Naoto Nakamichi 89 168 98 51 22 358
Jiadai Xu 100 139 80 43 42 272
Dorota Lemancewicz 96 130 100 47 35 352
Zohar Sachs 133 239 82 78 36 369
Izabela Dróźdż 174 223 116 39 26 353
Mingzhen Yang 89 126 36 44 27 288
Ligen Liu 132 160 84 62 28 349
Zonghong Shao 171 169 71 35 34 332
Xiang-shan Cao 148 151 21 114 22 355
Kaveh Jaseb 164 91 42 47 36 329

All Works

Loading papers...

Rankless by CCL
2026